Synthetic modification of salinomycin: Selective O-acylation and biological evaluation

Chemical Communications

Volumn 49, Issue 85, 2013, Pages 9944-9946

  Borgström, Björn ^a   Huang, Xiaoli ^a   Martin, Pošta ^a   Hegardt, Cecilia ^a   Oredsson, Stina ^a   Strand, Daniel ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYL GROUP; SALINOMYCIN;

ACYLATION; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER PREVENTION; CANCER RECURRENCE; CANCER STEM CELL; CHEMICAL MODIFICATION; DOSE RESPONSE; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING;

ACYLATION; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; PYRANS;

EID: 84885121121     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c3cc45983g     Document Type: Article

References (31)

1. M. Dean, T. Fojo, S. Bates: Nat. Rev. Cancer 2005 5: 275.
2. N. Y. Frank, T. Schatton, M. H. Frank: J. Clin. Invest. 2010 120: 41.
3. K. Sampieri, R. Fodde: Semin. Cancer Biol. 2012 22: 187.
4. C. Naujokat, R. Steinhart: J. Biomed. Biotechnol. 2012 2012: 950658.
5. P. B. Gupta, T. T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R. A. Weinberg, E. S. Lander: Cell 2009 138: 645.
6. Y. Miyazaki, M. Shibuya, H. Sugawara, O. Kawaguchi, C. Hirsoe: J. Antibiot. 1974 27: 814.
7. Y. Miyazaki, H. Kinashi, N. Otake, M. Mitani, T. Yamanishi: Agric. Biol. Chem. 1976 40: 1633.
8. Y. Kishi, S. Hatakeyama and M. D. Lewis, in Frontiers of Chemistry, ed. K. J. Laidler, Oxford, 1982
9. K. Horita, S. Nagato, Y. Oikawa, O. Yonemitsu: Chem. Pharm. Bull. 1989 37: 1698.
10. P. J. Kocienski, R. C. D. Brown, A. Pommier, M. Procter, B. Schmidt: J. Chem. Soc., Perkin Trans. 1 1998: 9.
11. A. Huczyński: Chem. Biol. Drug Des. 2012 79: 235.
12. A. Huczyński: Bioorg. Med. Chem. Lett. 2012 22: 7002.
13. R. Riccioni, M. L. Dupuis, M. Bernabei, E. Petrucci, L. Pasquini, G. Mariani, M. Cianfriglia, U. Testa: Blood Cells, Mol., Dis. 2010 45: 86.
14. D. S. Lu, M. Y. Choi, J. Yu, J. E. Castro, T. J. Kipps, D. A. Carson: Proc. Natl. Acad. Sci. U. S. A. 2011 108: 13253.
15. J.-H. Kim, M. Chae, W. K. Kim, Y.-J. Kim, H. S. Kang, H. S. Kim, S. Yoon: Br. J. Pharmacol. 2011 162: 773.
16. K. Ketola, M. Hilvo, T. Hyötyläinen, A. Vuoristo, A.-L. Ruskeepää, M. Orešič, O. Kallioniemi, K. Iljin: Br. J. Cancer 2012 106: 99.
17. B. Verdoodt, M. Vogt, I. Schmitz, S.-T. Liffers, A. Tannapfel, A. Mirmohammadsadegh: PLoS ONE 2012 7: e44132.
18. K.-Y. Kim, S.-N. Yu, S.-Y. Lee, S.-S. Chun, Y.-L. Choi, Y.-M. Park, C. S. Song, B. Chatterjee, S.-C. Ahn: Biochem. Biophys. Res. Commun. 2011 413: 80.
19. A. Huczyński, J. Janczak, M. Antoszczak, J. Wietrzyk, E. Maj, B. Brzezinski: Bioorg. Med. Chem. Lett. 2012 22: 7146.
20. A. Huczyński, J. Janczak, J. Stefanska, M. Antoszczak, B. Brzezinski: Bioorg. Med. Chem. Lett. 2012 22: 4697.
21. J. Tulla-Puche, Á. Torres, P. Calvo, M. Royo, F. Albericio: Bioconjugate Chem. 2010 3: 555.
22. J. González-Sabín, R. Morán-Ramallal, F. Rebolledo: Chem. Soc. Rev. 2011 40: 5321.
23. R. Tong, J. J. Cheng: Chem. Sci. 2012 3: 2234.
24. P. Hammann, W. Raether, L. Vertesy: J. Antibiot. 1993 46: 523.
25. K. C. Nicolaou, A. A. Estrada, M. Zak, S. H. Lee, B. S. Safina: Angew. Chem., Int. Ed. 2005 44: 1378.
26. J. Tulla-Puche, Á. Torres, P. Calvo, M. Royo, F. Albericio: Bioconjugate Chem. 2008 19: 1968.
27. A. Huczyński, J. Janczak, M. Antoszczak, J. Stefańska, B. Brzezinski: J. Mol. Struct. 2012 1002: 197.
28. M. E. Duggan, J. S. Imagire: Synthesis 1989: 131.
29. J. L. Wells, J. Bordner, P. Bowles, J. W. McFarland: J. Med. Chem. 1988 31: 274.
30. E. F. Paulus, M. Kurz, H. Matter, L. Vertesy: J. Am. Chem. Soc. 1998 120: 8209.
31. N. Matsumori, A. Morooka, M. Murata: J. Am. Chem. Soc. 2007 129: 14989.